Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. It is important that all stakeholders be involved in tackling the public health threat of obesity and obesity-related diseases, including MASLD. A simple and clear assessment and referral pathway using non-invasive tests is essential to ensure that patients with severe MASLD are identified and referred to specialist care, while patients with less severe disease remain in primary care, where they are best managed. While lifestyle intervention is the cornerstone of the management of patients with MASLD, cardiovascular disease risk must be properly assessed and managed because cardiovascular disease is the leading cause of mortality. No pharmacological agent has been approved for the treatment of MASLD, but novel anti-hyperglycemic drugs appear to have benefit. Medications used for the treatment of diabetes and other metabolic conditions may need to be adjusted as liver disease progresses to cirrhosis, especially decompensated cirrhosis. Based on non-invasive tests, the concepts of compensated advanced chronic liver disease and clinically significant portal hypertension provide a practical approach to stratifying patients according to the risk of liver-related complications and can help manage such patients. Finally, prevention and management of sarcopenia should be considered in the management of patients with MASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The growing yearly prevalence of Metabolic Dysfunction–non-alcoholic fatty liver disease (MASLD) has emerged as a worldwide public health concern, driven by improved living conditions, evolving lifestyle habits, and the widespread occurrence of obesity, diabetes, and metabolic syndrome.1”
From The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is because the clinical definition of MASLD, as previously noted, includes not only the presence of steatosis but also a cardiometabolic context [31,32,33], which cannot be fully reproduced in a monoculture of hepatocyte-like cells.”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“102 Of late, there is a growing interest in studies on the association between sarcopenia and MASLD.”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Cited by
Items 501–600 of 784
Incretin-based therapies: a new era in metabolic liver disease management
Elangovan, S., Cheah, C. C. M., & Goh, G. B. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2026.15 · Cited by 1
Kim, Y. H., Kim, J., An, D. Y., Park, M., Jeong, G.-H., Jin, J., Kim, M. K., Chin, J., Choi, Y., & Park, K. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01740-0 · Cited by 2
Fang, K., Miao, J., & Song, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1853302 · Cited by 1
Tsai, Y., Mudiyanselage, S. P. K., Tsai, Y., Maithreepala, S. D., Liu, W.-C., Ko, N., Yeh, J., Wei-Lin, C., Hsu, P.-I., Chou, C., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02208-x · Cited by 1
Rhee, M., Lee, J., Jung, C. W., Yang, J., Choi, W. G., You, Y., Park, H., Lee, E. Y., Lee, E. Y., Kwon, S. W., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.06.031 · Cited by 4
Suilik, H. A., Gadelmawla, A. F., Rifai, M. K., Alhawi, M., Ashour, A., Abdalshafy, H., Bataineh, O. A., Rezq, H. S., Hani, A. B., Elkhattib, I., et al. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103415 · Cited by 1
Tauriainen, M.-M., Lankinen, M. A., Hakumäki, J. M., Lahtinen, O., Husso, M., Ågren, J. J., Laakso, M., & Schwab, U. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04031-6 · Cited by 2
Burks, E., Copes, J., Nguyen, K., Tawil-Brown, A., & Yan, S. (2026) · Autophagy Reports · doi:10.1080/27694127.2026.2698350 · Cited by 2
Effectiveness of dietary modifications in reversing damage induced by high-fat diet in rats
Jiménez‐García, M., Quetglas‐Llabrés, M. M., Valdés, S. C. E., Ribas‐Taberner, M. D. M., Gomila, A., Moranta, D., & Tejada, S. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01205-y · Cited by 1
An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD
Dong, A., Li, N., Lang, X., Chen, S., Qin, Y., Wang, Y., Wang, H., Guo, M., Yan, A., Song, K., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103038 · Cited by 1
Araque, M., Garces, S. M., Yu, H., Zha, M., Qazi, S., Guo, Y., Goldberg, D. S., Agopian, V. G., McCauley, J. L., Flóres, Y. N., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.101077 · Cited by 1
Cortés-Reséndiz, A., Fernández‐Costa, J. M., Sabater-Arcis, M., Chiara, F. D., & Ramón‐Azcón, J. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052820 · Cited by 1
Lau, S. Y., Kok, V. S. L., Tan, S. S., Adnan, S. D., Ng, W. L., Ang, B. H., Yaacob, N. Y., Lee, Y. Y., Kaur, S., Mohamed, R. B., et al. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70643 · Cited by 2
Self-citationPeriodontitis and metabolic dysfunction‐associated steatotic liver disease
de Molon, R. S., de Ávila, É. D., Barbirato, D. D. S., Fogacci, M. F., Shibli, J. A., Sculean, A., & Kantarcı, A. (2026) · Periodontology 2000 · doi:10.1111/prd.70072 · Cited by 2
Nonalcoholic fatty liver disease associated with obesity and type 2 diabetes and gut dysbiosis
Bentsa, T. М. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.2.2024.1373 · Cited by 1
Hu, C., Yu, Z., Wei, C., Sheng, G., Chen, J., & Zou, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1338156 · Cited by 1
Doença hepática gordurosa não alcoólica: uma revisão da fisiopatologia ao tratamento
Virgolino, I. P. A. C., Paiva, C. R., Safieddine, F. H., Freitas, K. M. A., Bizzi, L. A., Ladeira, L. V. R., Viana, M. E. V. G., Pereira, R. R., & Bomfá, T. G. C. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n3-141 · Cited by 1
Song, S. J., Kim, Y. R., Lee, Y. H., & Cho, E. Y. (2024) · ULTRASONOGRAPHY · doi:10.14366/usg.24091 · Cited by 1
Saini, A., Rutledge, B. P., Damughatla, A. R., Rasheed, M., Naylor, P. H., & Mutchnick, M. G. (2024) · Healthcare · doi:10.3390/healthcare12151478 · Cited by 4
Zarei, A., Pashayee-Khamene, F., Hekmatdoost, A., Karimi, S., Ahmadzadeh, S., Saberifiroozi, M., Hatami, B., & Yari, Z. (2024) · BMC Research Notes · doi:10.1186/s13104-024-06928-z · Cited by 1
Ayesh, H. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001808 · Cited by 1
Kim, J.-S., Hong, S. M., Kim, D., & Cho, Y. (2024) · Nutrients · doi:10.3390/nu16213760 · Cited by 2
Agarwal, L., Varshney, V. K., Selvakumar, B., Soni, S. C., Varshney, P., & Agarwal, A. (2025) · Journal of Minimal Access Surgery · doi:10.4103/jmas.jmas_297_24 · Cited by 1
Ma, C. M., & Goldberg, D. S. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-08992-2 · Cited by 1
Disease-specific non-invasive assessment of liver fibrosis and portal hypertension
Cavoli, T. V. L., Curto, A., Lynch, E. N., Galli, A., & Milani, S. (2025) · Minerva Gastroenterology · doi:10.23736/s2724-5985.25.03845-8 · Cited by 1
Chen, H.-F., Chang, Y.-Y., Chen, P., Shen, X.-H., Chang, C.-H., & Hsu, W. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.104576 · Cited by 1
Blood Biomarkers Associated with Metabolic Syndrome: Implications for Public Health Screening
Jahić, R., & Fajkić, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_94-1 · Cited by 1
Mansour, A. M. F., Nashaat, E. H., Mohamed, A. G. S. H., & ElGhandour, A. M. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00419-x · Cited by 1
From cooperation to collapse: systemic failure in liver disease through a sociological lens
Wang, J., Lei, J., Harmsen, M. C., & Moshage, H. J. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100580 · Cited by 1
Iqbal, M. F., Nawaz, Z., Aamir, A., Kumar, N., & Kumar, N. K. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02054-4 · Cited by 1
Pyruvate Oxidation Sustains B Cell Antigen-Specific Activation to Exacerbate MASHPreprint
Barrow, F., Wang, H., Fredrickson, G., Florczak, K. L., Ciske, E., Khanal, S., Parthiban, P., Huy, N. T., Rios, E., Kostallari, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.13.566832 · Cited by 3
Mitochondrial Dysfunction in MASLD: Unveiling Mechanisms and Optimizing Therapeutic Strategies
Radosavljević, T. S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673322846240724063112 · Cited by 1
Gualdieri, F., Rocha, G. E., Iacono, R. F., Marzi, M. C. D., & Guerra, L. N. (2024) · Preprints.org · doi:10.20944/preprints202410.0635.v1 · Cited by 1
Hajaj, E., Bendersky, A. G., Braun, M., & Shlomai, A. (2024) · medRxiv · doi:10.1101/2024.10.26.24316188 · Cited by 1
Guan, L., Zhang, X., Liu, S., Qi, X., & Li, Y. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0921 · Cited by 1
When to refer patients for liver elastography
Șirli, R., Sporea, I., & Popescu, A. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2444554 · Cited by 1
Wang, K., Xiang, S., He, Q., Huang, C., Yang, Z. Y., Li, R., Liu, A., Cai, R., Mi, N., Liang, Z., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6026627/v1 · Cited by 1
Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030160 · Cited by 1
Li, L., Cong, C., Zhang, X., & Zhang, X. (2026) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s573711
MICROWAVE SPECTRUM AND STRUCTURE OF 2-CHLOROPROPIONITRILE
Ogata, T., & Yamashita, N. (1995) · The Knowledge Bank (The Ohio State University)
Olteanu, V. A. (2024) · The Medical-Surgical Journal · doi:10.22551/msj.2024.01.05
Kamuzinzi, H., Kgomo, M. K., Rheeder, P., Dada, N., & Bester, P. (2024) · South African Medical Journal · doi:10.7196/samj.2024.v114i6.1748 · Cited by 1
Posicionamiento sobre manejo perioperatorio y riesgo quirúrgico en el paciente con cirrosis
Velasco, J. A. V.-R., Crespo, J., Montaño‐Loza, A. J., Aldana-Ledesma, J. M., Cano-Contreras, A. D., Reyes, E. C., Pérez, N. J. F., Castro‐Narro, G., García-Jiménez, E. S., Lira-Vera, J. E., et al. (2024) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.05.001
Liver Disease as a Potential Risk Factor for Colorectal Cancer: A Community Hospital Experience
Aillaud‐De‐Uriarte, D., HERNÁNDEZ-FLORES, L. A., Zachariah, P. N., Bhatia, R., Manzano-Cortés, H., & Copado, D. M. (2024) · Cureus · doi:10.7759/cureus.62400
Bertran, L., Rusu, E. C., Aguilar, C., Auguet, T., & Richart, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4641049/v1
Kruszewski, A., Dąbrowska, A., Przybysz, P., Kucharska, M., Szyszka, M., Paduszyńska, N., & Błaszczak, K. (2024) · Quality in Sport · doi:10.12775/qs.2024.17.53023
Bertran, L., Aguilar, C., Auguet, T., & Richart, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4996482/v1
Garza, A. C. G., Martínez, B. B., Abarca, R. S. G., Silva, V. S., & Greene, E. J. D. (2024) · Acta Médica Grupo Ángeles · doi:10.35366/117516 · Cited by 1
Hepatoprotective Benefits of SGLT-2 Inhibitors and GLP-1 Analogs
Rajagopal, D., & Rashid, S. A. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_128_24
Double Trouble: Metabolic Dysfunction-Associated Fatty Liver Disease in Fraternal Twins
Bondurant, J., & Paul, S. (2024) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2024.10.012
Zhaivoronok, M., Dynnyk, O., Nosenko, T., & Kobyliak, N. M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5016761
Athar, R., Shahsavan, M., Shahmiri, S. S., Pazouki, A., Husain, F. A., & Kermansaravi, M. (2024) · Surgical Laparoscopy Endoscopy & Percutaneous Techniques · doi:10.1097/sle.0000000000001347 · Cited by 1
Rogalski, J. K., Gawlik-Kotelnicka, O., & Tomczak, T. (2024) · Current Problems of Psychiatry · doi:10.12923/2353-8627/2024-0021
Ortiz‐López, N., de la Barra, M. A., Vergara, T., Aleman, L., Jaime Poniachik, T., & Beltrán, C. J. (2024) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2024.76982 · Cited by 2
Frey, B. N., Hyun, D., Simson, W. A., Brevett, T. E. A., Zhuang, L. L., Baek, J., Sanabria, S. J., & Dahl, J. (2024) · IEEE Ultrasonics, Ferroelectrics, and Frequency Control Joint Symposium (UFFC-JS) · doi:10.1109/uffc-js60046.2024.10794091
Levesley, C. R., Zhang, X., Barnett, S. D., Henry, L. L., Cheung, R. C., & Nguyen, M. H. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5073210
Shestakova, D. Y., & Borsukov, A. V. (2024) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2024-52-037
Méndez‐Sánchez, N., Ramírez-Mejía, M. M., & Eslam, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_1
Méndez‐Sánchez, N., Ramírez-Mejía, M. M., & Qi, X. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_2 · Cited by 2
Esteatosis hepática evaluada por tomografía en una población adulta de Cali, Colombia
Izquierdo-Ordoñez, J. E., Mafla-Rodríguez, D., Blanco-Romero, V., Delgado-Urriago, A., Ardila, W., Mora, J. F., & Valdés-Torres, F. (2025) · Hepatología · doi:10.59093/27112330.118
林, 于. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152520
Gil, L. D. L. H., Martínez-Echevarría, V. S., & Lozano-Estevan, M. D. C. (2025) · Nutrición Hospitalaria · doi:10.20960/nh.05252
James, L., Pansini, M., Diamond, C., Al‐Mossawi, H., Banerjee, R., Thomaides-Brears, H. B., & Coates, L. C. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf177
Paramasivam, P., Bravo, G. M., Coffman, B. B., Rajaiya, J., Monga, S. P., & Mota, R. I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.09.648024
Brion, C., Hoang, S. A., Wang, G., Mirshahi, F., Ang, J., Long, M., Zheng, Z., Sakhamuri, B., Srour, M. A., Siddiqui, M. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.08.647685
Ross, J. M., Kim, A., Berthod, K., Branca, R. M., Olin, M., Pichardo‐Casas, I., Lehtiö, J., Björkhem, I., Sinclair, D. A., Olson, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650453
Tsai, Y., Mudiyanselage, S. P. K., Maithreepala, S. D., Tsai, Y., Liu, W., Ko, N., Yeh, J., Wei-Lin, C., Shen, D. C.-J., Hsu, P., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5242628
Cai, M., Wang, Y., Zhu, J., & Guo, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-6524632/v1 · Cited by 1
Stetson, A. E., Herdes, R. E., Kochis, M. A., Bizimana, C., Sy, M., Beltran, F., Nzenwa, I. C., Filho, J. C. J. P., Pratt, J. S. A., & Griggs, C. L. (2025) · Research Square · doi:10.21203/rs.3.rs-6480681/v1
Evolving Public Attention to Steatotic Liver Disease: A 20‐Year Analysis (2004–2024)
Danpanichkul, P., Thongprayoon, C., Suparan, K., Kim, D., Wanichthanaolan, O., Wattanachayakul, P., Pang, Y., Muthiah, M. D., Kulkarni, A. V., Yang, J. D., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.17009
Goulart, A. C., Alencar, A. P., da Silva, G. T., Bianchi, L. L. T., Miname, M. H., Padilha, C., Pescuma, J. M. S., Rodrigues, A. L. C. C., Henares, B. B., de Almeida, M. S., et al. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2025e14538
Фофанова, О. Ю., Феденько, В. В., Гурик, З., Кіндратів, Е. О., & Лаб'як, І. Г. (2025) · Art of Medicine · doi:10.21802/artm.2025.2.34.113
Niersmann, C., Zhu, A., Maalmi, H., Cai, X., Nano, J., Rathmann, W., Köenig, W., Takamura, T., Kollerits, B., Dieplinger, H., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70095
Huang, X., Wu, M., Wu, Z., Lu, K., Lin, Y., Ho, K., & Zhang, Y. (2025) · Medicine · doi:10.1097/md.0000000000043250
Roy, A., & Goenka, M. K. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes25055
Sarcopenia associated with liver diseases and biliary tract
Данисовна, С. Л., Gantseva, K. K., Akhiiarova, K. E., Khafizov, M. M., & Tyurin, A. V. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-171-177
Metabolic Dysfunction-Associated Steatotic Liver Disease: a rapidly growing common liver disease
Brennan, A. (2025) · Gastrointestinal Nursing · doi:10.12968/gasn.2024.0120r3
Bhawariya, S., Bhardwaj, A., Singh, A., Sharma, R., Kapoor, R., Bawa, A., Joshi, L., & Bhardwaj, G. (2025) · Cureus · doi:10.7759/cureus.88636 · Cited by 1
Boonto, T., & Ariyachet, C. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106795
Migacz, M., Pluta, D., Barański, K., Kujszczyk, A., Kochanowicz, M., & Holecki, M. T. (2025) · Biomedicines · doi:10.3390/biomedicines13081878
Nanizawa, E., Katoh, Y., Tamaki, Y., Otsuka, S., Hatayama, N., Ishikawa, T., Hirai, S., & Naito, M. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110049
Mediation analysis of the molecular phenotypes in a severe MASH-like liver injury mouse model
Song, Z., Tryndyak, V., Willett, R. A., Pogribny, I. P., Rusyn, I., & Wright, F. A. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf116
Lee, J., Kang, E. S., Jeong, S., & Lee�, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-62833-4
Watanabe, K., Nishioka, H., Takubo, M., Kosuda, M., Yamamotoya, T., Saigusa, T., & Ishihara, H. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109150
MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortality
Reyes-Barrera, J., Posadas‐Sánchez, R., Vargas‐Alarcón, G., Cardoso-Saldaña, G. C., Almeda‐Valdés, P., Bello‐Chavolla, O. Y., Ortiz-Hernández, L., & Antonio‐Villa, N. E. (2025) · Scientific Reports · doi:10.1038/s41598-025-15487-7
Koçak, T., Danış, N., Döngelli, H., Ağalar, A. A., Bengı, G., & Akarsu, M. (2025) · Revista de investigaci�n Cl�nica · doi:10.1016/j.ric.2025.100016 · Cited by 2
Griffin, G., Delnicki, M. E., Lü, H., Meaza, I., Williams, A., Vielee, S. T., Bolatimi, O. E., Wise, R. M., Liu, R., Kouokam, J. C., et al. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127731 · Cited by 1
Coffee and Metabolic Syndrome/MAFLD
Cicero, A. F. G., Fogacci, F., & Micoli, V. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-93459-9_22
Ongoth, F. E. M., Kondo, R. G., Apendi, P. C. M. A., Mbamognoua, N. G. A., Mayanda, R. L., Okoumou-Moko, A., Dinghat, O. M. Y., Ekoundzola, J. R., Eloi, S. N., Moyikoua, R., et al. (2025) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2025.158014 · Cited by 1
Jiang, Y., Xiong, Q., Zhu, X., Hou, M., & Deng, Z. (2025) · Biomedical Chromatography · doi:10.1002/bmc.70200
Bile acids for metabolic dysfunction-associated steatotic liver disease in adults
Ashmawy, R. E., Blyuss, O. B., Nikolova, D., Pavlov, C. S., Gluud, C. N., & Andrenacci, P. J. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014850 · Cited by 1
Huang, H., Luo, T., Lu, Y., Wu, H., Li, J., Tang, T., Xv, X., Wu, J., & Chen, M. (2025) · Research Square · doi:10.21203/rs.3.rs-7188234/v1
Huynh, T. M., Chien, N. V., Ly, D. T., Hung, H. M. J., Ong, P. T., Vo, T. L. T., Vo, T. D., & Quach, D. T. (2025) · medRxiv · doi:10.1101/2025.09.01.25334851
Maldonado, A., Torres, E., Flores, M. A., Rodriguez, M., Villavicencio, E. A., Torres, R., Castro, I., Torres, F., Loya, J., Alkhouri, N., et al. (2025) · SSM - Population Health · doi:10.1016/j.ssmph.2025.101862 · Cited by 2
Su, Y., Min, S. H. I., Yang, B., & Zhou, H. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0166
Mashiki, S., Matsuoka, N., Urakawa, Y., Osada, N., Hirashima, Y., Fujiki, K., Ogami, T., Kamiya, T., Takagaki, K., & Iwama, Y. (2025) · Food and Nutrition Sciences · doi:10.4236/fns.2025.169069
Banisefid, E., Zonouzi, S. K., Hamzehzadeh, S., Nikniaz, Z., Moghaddamziabari, S., & Alizadeh, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-16787-8
Elsabaawy, M., Fathlla, A., Abelwahed, M., Loulah, S., Badr, A., & Darwesh, N. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00546-2
Price, F., van den Berg, L., Schutte, F. N., Bezuidenhout, A., Smit, J., Francis, E., Nel, M., & Robb, L. (2025) · South African Journal of Surgery · doi:10.36303/sajs.02611
Metadata
- Authors
- Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R.
- Affiliations
- University of Malaya (MY)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Chan, Wah-Kheong
- Venue
- Journal of Obesity & Metabolic Syndrome
- Published
- 2023-09-13
- Volume
- 32
- Issue
- 3
- Pages
- 197-213
- ISSN
- 2508-6235 (ISSN-L)
- 2508-7576
- PMC
- PMC10583766
- OpenAlex
- W4386704735
- Cited by
- 776
- References
- 122
- Citations by year
- 2026: 245 · 2025: 342 · 2024: 183 · 2023: 5
- FWCI
- 30.29
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Journal of Obesity & Metabolic Syndrome (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, metabolic syndrome, obesity, chronic liver disease, non-invasive liver assessment, referral pathways, lifestyle intervention, cardiovascular risk, anti-hyperglycemic drugs, liver cirrhosis, decompensated cirrhosis, compensated advanced chronic liver disease, clinically significant portal hypertension, sarcopenia, liver complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.